[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=db06f8e6277ee916a9d2e4aa9444e102267f50158392285b3cbb5028fc9cce34",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736181960,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "id": 132327314,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=db06f8e6277ee916a9d2e4aa9444e102267f50158392285b3cbb5028fc9cce34"
    }
  },
  {
    "ts": null,
    "headline": "Ultragenyx’s Evkeeza secures EU approval for young children with rare cholesterol disorder",
    "summary": "The decision follows a positive recommendation received from the Committee for Medicinal Products for Human Use (CHMP) in November 2024.",
    "url": "https://finnhub.io/api/news?id=631f4fb2772743bf8481b9cc162ba00273b4a9581e2dbfeabf0707a3bc9749ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736168826,
      "headline": "Ultragenyx’s Evkeeza secures EU approval for young children with rare cholesterol disorder",
      "id": 132286678,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/24/2025/01/GettyImages-1996370129-e1736162547281.jpg",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "The decision follows a positive recommendation received from the Committee for Medicinal Products for Human Use (CHMP) in November 2024.",
      "url": "https://finnhub.io/api/news?id=631f4fb2772743bf8481b9cc162ba00273b4a9581e2dbfeabf0707a3bc9749ad"
    }
  }
]